Safety and effectiveness of Rixubis in patients with hemophilia B: A real-world, prospective, postmarketing surveillance study in South Korea.

Conclusions: Rixubis demonstrated an acceptable safety and effectiveness profile in the treatment of bleeding, perioperative management, and prophylaxis in hemophilia B patients in a real-world setting in South Korea. PMID: 33303707 [PubMed - as supplied by publisher]
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research